The patients were divided into three groups: Group A (28 patients, mean age 56.3 4.7 years, mean BMI 35.3 3.0 kg/m 2 ), Group B (30 patients, mean age 55.1 5.2 years, mean BMI 34.6 3.4 kg/m 2 ), and Group C (25 patients, mean age 54.0 6.5 years, mean BMI 35.0 4.3 kg/m 2 )
NAC is a drug of interest in the early treatment of COVID-19 due to its antioxidant properties, although it has not yet been proven to decrease mortality rates [95]
Notably, the reductions observed in these parameters were greater than those seen with semaglutide 1 mg, another GLP-1 receptor agonist, in the SUPRASS-2 trial.Tirzepatide was generally well-tolerated, with a low risk of hypoglycaemia when used without insulin or insulin secretagogues
Rice AJ, Gadgil MG, Bisignano P, Stein RA, McHaourab HS, Mitchell DA
Keep in mind that glutathione IV typically isnt a one-and-done treatment, requiring 10 injections over a span of 10 weeks, followed by monthly maintenance